Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine and Bupropion for Meniere's Disease
NCT05420350Phase 2Unknown
- Sponsor
- Dent Neurosciences Research Center, Inc.
- Start
- Dec 2020
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Meniere's disease (MD) comparing Lamotrigine and Bupropion with Placebo (2 arms). Primary endpoints: Change in Ménière's vertigo attack frequency between groups and Change in Ménière's vertigo attack frequency lamotrigine alone compared to lamotrigine and bupropion. Status: unknown.
02
Drugs
lamotriginebupropion
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT05420350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05420350.